Anti-NBPF8 monoclonal antibody

Pre-made anti-NBPF8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NBPF8/NBPF8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2897-Ab-1/ GM-Tg-hg-IP2897-Ab-2Anti-Human NBPF8 monoclonal antibodyHuman
GM-Tg-rg-IP2897-Ab-1/ GM-Tg-rg-IP2897-Ab-2Anti-Rat NBPF8 monoclonal antibodyRat
GM-Tg-mg-IP2897-Ab-1/ GM-Tg-mg-IP2897-Ab-2Anti-Mouse NBPF8 monoclonal antibodyMouse
GM-Tg-cynog-IP2897-Ab-1/ GM-Tg-cynog-IP2897-Ab-2Anti-Cynomolgus/ Rhesus macaque NBPF8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2897-Ab-1/ GM-Tg-felg-IP2897-Ab-2Anti-Feline NBPF8 monoclonal antibodyFeline
GM-Tg-cang-IP2897-Ab-1/ GM-Tg-cang-IP2897-Ab-2Anti-Canine NBPF8 monoclonal antibodyCanine
GM-Tg-bovg-IP2897-Ab-1/ GM-Tg-bovg-IP2897-Ab-2Anti-Bovine NBPF8 monoclonal antibodyBovine
GM-Tg-equg-IP2897-Ab-1/ GM-Tg-equg-IP2897-Ab-2Anti-Equine NBPF8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2897-Ab-1/ GM-Tg-hg-IP2897-Ab-2; GM-Tg-rg-IP2897-Ab-1/ GM-Tg-rg-IP2897-Ab-2;
GM-Tg-mg-IP2897-Ab-1/ GM-Tg-mg-IP2897-Ab-2; GM-Tg-cynog-IP2897-Ab-1/ GM-Tg-cynog-IP2897-Ab-2;
GM-Tg-felg-IP2897-Ab-1/ GM-Tg-felg-IP2897-Ab-2; GM-Tg-cang-IP2897-Ab-1/ GM-Tg-cang-IP2897-Ab-2;
GM-Tg-bovg-IP2897-Ab-1/ GM-Tg-bovg-IP2897-Ab-2; GM-Tg-equg-IP2897-Ab-1/ GM-Tg-equg-IP2897-Ab-2
Products NameAnti-NBPF8 monoclonal antibody
Formatmab
Target NameNBPF8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NBPF8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2897-Ag-1Recombinant multi-species NBPF8/ NBPF8P protein


    Target information

    Target IDGM-IP2897
    Target NameNBPF8
    Gene ID728841
    Gene Symbol and SynonymsNBPF8,NBPF8P
    Uniprot AccessionQ3BBV2
    Uniprot Entry NameNBPF8_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000270231
    Target ClassificationN/A

    The target: NBPF8, gene name: NBPF8, also named as NBPF8P. This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. Gene copy number variations in the human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Apr 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.